Perrigo | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.86B 306M 2024-12
Abbott USD 2.91B 21M 2024-12
Bayer EUR 4.34B 610M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Dr.Reddys Laboratories INR 24.12B 10.91B 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
J&J USD 6.45B 975M 2024-12
Merck USD 2.85B 148M 2024-12
Nestle CHF 12.91B 6.52B 2024-12
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Prestige Brands USD 64.13M 3.35M 2024-12
Sanofi EUR 2.68B 26M 2024-09
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12
Zoetis USD 625M 60M 2024-12



Perrigo Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.